EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

EUR J PHARM SCI
影响因子:4.7
JCR分区:Q1
新锐分区:医学2区
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:NETHERLANDS
出版社:Elsevier
发刊时间:1993
收录数据库:SCIE/Scopus收录
ISSN:0928-0987

期刊介绍

The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development.More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making.Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.
该杂志发表的研究文章,评论文章和科学评论的所有方面的制药科学,重点是概念新奇和科学质量。编辑们欢迎这一多学科领域的文章,重点关注与药物发现和开发相关的主题。更具体地说,该杂志发表的报告涉及药物化学、药理学、药物吸收和代谢、药代动力学和药效学、药物和生物医学分析、药物递送(包括基因递送)、药物靶向、制药技术、制药生物技术和临床药物评价。该杂志通常不会优先考虑主要关注有机合成、天然产物、分析方法的适应性或与药物政策制定有关的讨论的稿件。科学评论和综述文章通常仅限邀请或经编辑同意。科学会议的议事录可作为《日刊》的特刊或增刊出版。
年发文量 263
国人发稿量 91
国人发文占比 0.35%
自引率 -
平均录取率0
平均审稿周期 平均3.0个月平均6.3周
版面费 US$2300
偏重研究方向 医学-药学
期刊官网 http://www.elsevier.com/wps/find/journaldescription.cws_home/523997/description
投稿链接 https://www.editorialmanager.com/PHASCI

期刊高被引文献

Tyrosine kinase inhibitor conjugated quantum dots for non‐small cell lung cancer (NSCLC) treatment
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.026
Development of the 1,2,4‐triazole‐based anticonvulsant drug candidates acting on the voltage‐gated sodium channels. Insights from in‐vivo, in‐vitro, and in‐silico studies
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.12.018
Hot melt extrusion technology for improved dissolution, solubility and “spring‐parachute” processes of amorphous self‐micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.019
A dynamic in vitro permeation study on solid mono‐ and diacyl‐phospholipid dispersions of celecoxib
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.003
Enhanced transdermal permeation and anti‐inflammatory potential of phospholipids complex‐loaded matrix film of umbelliferone: Formulation development, physico‐chemical and functional characterization
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.02.006
New thiobarbituric acid scaffold‐based small molecules: Synthesis, cytotoxicity, 2D‐QSAR, pharmacophore modelling and in‐silico ADME screening
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.023
Exploiting gelatin nanocarriers in the pulmonary delivery of methotrexate for lung cancer therapy
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.016
Solubility‐pH profile of desipramine hydrochloride in saline phosphate buffer: Enhanced solubility due to drug‐buffer aggregates
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.014
The use of heat and chemical penetration enhancers to increase the follicular delivery of erythromycin to the skin
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.02.030
Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.10.011
Evaluation of self‐nanoemulsifying drug delivery systems using multivariate methods to optimize permeability of captopril oral films
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.039
The EU regulatory landscape of non‐biological complex drugs (NBCDs) follow‐on products: Observations and recommendations
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.029
PD‐L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer‐Immunity Cycle for melanoma treatment
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.10.021
Development of injectable liposomes and drug‐in‐cyclodextrin‐in‐liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.10.006
Further enhanced dissolution and oral bioavailability of docetaxel by coamorphization with a natural P‐gp inhibitor myricetin
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.12.016
Towards modern anticancer agents that interact with tubulin
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.028
Production of “biobetter” glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatment
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.10.014
The impact of gastrointestinal mucus on nanoparticle penetration – in vitro evaluation of mucus‐penetrating nanoparticles for photodynamic therapy
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.010
Inclusion complexes of &bgr;‐cyclodextrin and polymorphs of mebendazole: Physicochemical characterization
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.012
Preparation, preliminary pharmacokinetic and brain targeting study of metformin encapsulated W/O/W composite submicron emulsions promoted by borneol
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.019
Visualization of the penetration modifying mechanism of laurocapram by Mass Spectrometry Imaging in buccal drug delivery
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.011
Hybrid Ear Cubes for local controlled dexamethasone delivery to the inner ear
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.04.045
Contribution of NHE3 and dietary phosphate to lithium pharmacokinetics
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.008
The safety profile of new antidiabetic xanthine derivatives and their chitosan based formulations
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.10.015
PIV measurements of the SimInhale benchmark case
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.025
Co‐encapsulation of acyclovir and curcumin into microparticles improves the physicochemical characteristics and potentiates in vitro antiviral action: Influence of the polymeric composition
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.02.019
On‐line rheological characterization of semi‐solid formulations
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.014
Evaluation of in‐line particle measurement with an SFT‐probe as monitoring tool for process automation using a new time‐based buffer approach
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.026
Tacrolimus‐loaded methoxy poly(ethylene glycol)‐block‐poly(D,L)‐lactic–co‐glycolic acid micelles self‐assembled in aqueous solution for treating cornea immune rejection after allogenic penetrating keratoplasty in rats
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.023
Examining P‐gp efflux kinetics guided by the BDDCS ‐ Rational selection of in vitro assay designs and mathematical models
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.005
Use of roller compaction and fines recycling process in the preparation of erlotinib hydrochloride tablets
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.036
Pharmacokinetic interaction of calcitriol with 20(S)‐protopanaxadiol in mice: Determined by LC/MS analysis
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.016
Evaluation of a transtympanic delivery system in Mus musculus for extended release steroids
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.01.020
Time dependent HPLC analysis of the product ratio of enzymatically reduced prodrug CB1954 by a modified and immobilised nitroreductase
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.001
Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.034
New unique PAT method and instrument for real‐time inline size characterization of concentrated, flowing nanosuspensions
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.024
Aryl‐urea fatty acids that activate the p38 MAP kinase and down‐regulate multiple cyclins decrease the viability of MDA‐MB‐231 breast cancer cells☆
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.12.015
Pharmacokinetics, bioavailability and tissue distribution study of JCC‐02, a novel N‐methyl‐D‐aspartate (NMDA) receptor inhibitor, in rats by LC‐MS/MS
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.02.018
Synthesis and structure‐activity‐relationship of 3,4‐Diaryl‐1H‐pyrrolo[2,3‐b]pyridines as irreversible Inhibitors of mutant EGFR‐L858R/T790M
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.021
A new, vasoactive hybrid aspirin containing nitrogen monoxide‐releasing molsidomine moiety
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.02.020
Breakpoint determination when multiple organisms are tested for effect targets
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.033
A novel oxazolidinone derivative PH192 demonstrates anticonvulsant activity in vivo in rats and mice
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.011
Sacubitril/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.037
Spectroscopic analysis of the influence of various external factors on ethenzamide‐glutaric acid (1:1) cocrystal formation
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.017
Tadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatment
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.04.001
Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.04.004
Single‐ and multiple‐dose pharmacokinetics of the peripheral non‐narcotic antitussive moguisteine in healthy Chinese volunteers
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.029
Mitochondria‐targeting nanomedicine: An effective and potent strategy against aminoglycosides‐induced ototoxicity
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.04.027
Beta‐glucan and arabinogalactan‐based xerogels for abuse‐deterrent opioid formulations
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.003
Extraction of levetiracetam for therapeutic drug monitoring by transdermal reverse iontophoresis
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.020

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
95.82%94.83%-0.28%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
PHARMACOLOGY & PHARMACY
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2026年3月发布
(新锐分区)
医学2区
PHARMACOLOGY & PHARMACY 药学
2区
2025年3月升级版
医学3区
PHARMACOLOGY & PHARMACY 药学
2区
2023年12月旧的升级版
医学3区
PHARMACOLOGY & PHARMACY 药学
2区

相关文章